A hyaluronic acid–camptothecin nanoprodrug with cytosolic mode of activation for targeting cancer†
Abstract
We have developed a nanoprodrug that enables the uptake by cancer cells and the subsequent intracellular
* Corresponding authors
a
Division of Polymer Chemistry, Department of Materials Chemistry, Uppsala University, Uppsala, Sweden
E-mail:
dmitri.ossipov@kemi.uu.se
Fax: +46 18 471 3477
Tel: +46 18 471 7335
We have developed a nanoprodrug that enables the uptake by cancer cells and the subsequent intracellular
X. Yang, I. Dogan, V. R. Pannala, S. Kootala, J. Hilborn and D. Ossipov, Polym. Chem., 2013, 4, 4621 DOI: 10.1039/C3PY00402C
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content